PUBLIC CONTRACT · 2021

4160193/2021 - Bevacizumab 400 mg (25 mg/ml AMP 16 ml) sol inj_bevacizumab 100 mg (25 mg/ml AMP 4 ml) sol inj

Contract value: €11,368.50
Signed on: 13 October 2021
Procedure: Direct award, general (Ajuste Direto Regime Geral)

This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 8773003

PUBLISHED SUBJECT

4160193/2021 - BEVACIZUMAB 400 MG (25 MG/ML AMP 16 ML) SOL INJ_BEVACIZUMAB 100 MG (25 MG/ML AMP 4 ML) SOL INJ

WHO CONTRACTED

Parties involved

Contracting body: Centro Hospitalar Barreiro Montijo, E. P. E.
Awardee: ROCHE FARMACEUTICA QUIMICA LDA
Place of performance: Portugal, Setúbal, Barreiro
NUTS region: Not stated

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee: ROCHE FARMACEUTICA QUIMICA LDA · Tax ID 500233810

HOW MUCH AND WHEN

Values and timeline

Contract price: €11,368.50
Procedure base price: €11,368.50
Total effective price: €11,368.50
Publication date: 24 January 2022
Award date: 13 October 2021
Signing date: 13 October 2021
Performance period: 1 days

The contract price is the value agreed in the contract, not the amount paid.

HOW IT WAS CONTRACTED

Procedure and framework

Contract type: Aquisição de bens móveis
Procedure type: Direct award, general (Ajuste Direto Regime Geral)
Award criterion: Monofator
CPV code: 33600000-6 - Produtos farmacêuticos
Legal basis: Artigo 24.º, n.º 1, alínea e), subalínea ii) do Código dos Contratos Públicos
Regime: Código dos Contratos Públicos ( DL 111-B/2017 )
Framework agreement: Not stated
Centralised procedure: No
Environmental criterion: No
Notice: Not stated
Procedure identifier: 5747918

KEEP EXPLORING

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts